The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats (Q28299609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

title

The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

Pekka Rauhala

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

author name string

E Nissinen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

H Nissinen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

H Larjonmaa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

A Väänänen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

T Helkamaa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

22 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

1213-1221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00702-004-0262-4

Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-004-0262-4

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-004-0262-4

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-004-0262-4

Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease

21 January 2018

1 reference

12 December 2020

Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease

1 reference

12 December 2020

Nigral endothelial dysfunction, homocysteine, and Parkinson's disease

1 reference

12 December 2020

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

1 reference

12 December 2020

Levodopa-induced hyperhomocysteinaemia in Parkinson's disease

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

1 reference

12 December 2020

3-OMD and homocysteine plasma levels in parkinsonian patients

1 reference

12 December 2020

Biological and clinical implications of the MTHFR C677T polymorphism

1 reference

12 December 2020

Homocysteine concentrations and methionine loading in patients on antiepileptic drugs

1 reference

12 December 2020

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial

1 reference

12 December 2020

Homocysteine and vascular disease

1 reference

12 December 2020

Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease

1 reference

12 December 2020

Elevated plasma levels of homocysteine in Parkinson's disease

1 reference

12 December 2020

Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease

1 reference

12 December 2020

New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

1 reference

12 December 2020

Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats

1 reference

12 December 2020

Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Nomecomt Study Group

1 reference

12 December 2020

Homocysteine in neuropsychiatric disorders of the elderly

1 reference

12 December 2020

Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD

1 reference

12 December 2020

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: a comparative study in the rat

1 reference

12 December 2020

Homocysteine in cerebral macroangiography and microangiopathy

1 reference

12 December 2020

Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians

1 reference

12 December 2020

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

12 December 2020

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

12 December 2020

Human liver catechol-O-methyltransferase pharmacogenetics

1 reference

12 December 2020

10.1007/S00702-004-0262-4

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15614425 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017